Palestrina, Italy

Giuliano Elia

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Consiglio Nazionale Delle Ricerche, Consiglio Nazionale Delle Richerche. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giuliano Elia. Retrieved from https://idiyas.com/inventor/giuliano-elia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Giuliano Elia: Innovator in Anti-Inflammatory Research

Introduction

Giuliano Elia is a notable inventor based in Palestrina, Italy. He has made significant contributions to the field of anti-inflammatory research, holding a total of 3 patents. His work focuses on the development of compounds that inhibit the NF-kB factor, which plays a crucial role in inflammatory responses.

Latest Patents

Elia's latest patents include innovative compounds such as 2-cyclopenten-1-one and its derivatives. These compounds are recognized for their ability to act as inhibitors of the NF-kB factor, showcasing anti-inflammatory, anti-proliferative, immunosuppressive, cytoprotective, and antiviral activities. The substituents in these compounds are carefully selected to ensure they do not affect the NF-kB inhibitory activity, making them valuable in therapeutic applications.

Career Highlights

Throughout his career, Giuliano Elia has worked with esteemed organizations, including the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). His research has contributed to advancements in understanding and treating inflammatory conditions.

Collaborations

Elia has collaborated with notable colleagues such as Antonio Rossi and Maria Gabriella Santoro. These partnerships have further enriched his research and innovation in the field.

Conclusion

Giuliano Elia's work in developing NF-kB inhibitors represents a significant advancement in anti-inflammatory research. His contributions continue to impact the scientific community and pave the way for future innovations in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…